
USA - NYSEARCA:CRHM -
The current stock price of CRHM is 3.99 null. In the past month the price increased by 1.53%. In the past year, price increased by 102.54%.
CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.
CRH Medical Corp
619 - 999 CANADA PLACE WORLD TRADE CENTER
VANCOUVER A1 V6C 3E1
CEO: Tushar Ramani
Phone: 604-633-1440
CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.
The current stock price of CRHM is 3.99 null.
CRHM does not pay a dividend.
CRHM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
You can find the ownership structure of CRH Medical Corp (CRHM) on the Ownership tab.
ChartMill assigns a technical rating of 9 / 10 to CRHM. When comparing the yearly performance of all stocks, CRHM is one of the better performing stocks in the market, outperforming 87.83% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to CRHM. CRHM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CRHM reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -180% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -23.05% | ||
| ROA | -12.76% | ||
| ROE | N/A | ||
| Debt/Equity | 0.67 |